OptimizeRx (OPRX) Non-Current Debt (2010 - 2026)

OptimizeRx (OPRX) has 6 years of Non-Current Debt data on file, last reported at $21.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 36.84% year-over-year to $21.3 million; the trailing twelve-month figure through Mar 2026 stood at $21.3 million (down 36.84% YoY), and the FY2025 full-year result was $21.4 million, down 30.49% from the prior year.
• Non-Current Debt held at $21.3 million in Q1 2026, from $21.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $34.2 million in Q4 2023 to a low of $21.3 million in Q1 2026.
• A 4-year average of $29.8 million and a median of $31.6 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt rose 4.25% in 2025 and slumped 36.84% in 2026, its largest moves.
• Tracing OPRX's Non-Current Debt over 4 years: stood at $34.2 million in 2023, then decreased by 9.98% to $30.8 million in 2024, then tumbled by 30.49% to $21.4 million in 2025, then dropped by 0.36% to $21.3 million in 2026.
• Business Quant data shows OPRX's Non-Current Debt at $21.3 million in Q1 2026, $21.4 million in Q4 2025, and $28.8 million in Q3 2025.